2010 revenues of $286.2 million 2010 net income of $51.7 million, or $1.63 per share, representing ninth consecutive year of profitability 2010 cash, investments and accounts receivable balance of $21… more →
Fuad El-Hibri Blogwrote 1 week ago: It’s the one I told you about days ago, the one uploaded (short version) in youtube. And yes. … more →
wrote 2 months ago: By JUDITH KONAYUMA TOP scientists have mooted a global plan of action for the development of vaccine … more →
wrote 5 months ago: “Recerca en Acció” is a portal made by the Catalan Government through the foundation dev … more →
wrote 1 year ago: 2,784 non-white babies from the poorest Cape Town communities hold the key to finding a new TB vacci … more →
wrote 1 year ago: 2010 revenues of $286.2 million 2010 net income of $51.7 million, or $1.63 per share, representing n … more →
wrote 1 year ago: ROCKVILLE, Md., Mar 24, 2011 (BUSINESS WIRE) — Emergent BioSolutions Inc. (NYSE:EBS) today released … more →
wrote 2 years ago: TUESDAY, Feb. 9 (HealthDay News) — A new vaccine prevents tuberculosis in people with HIV, a new stu … more →
wrote 2 years ago: Fuad El-Hibri’s EBS is Developing TB Vaccine “The search for a new TB vaccine is a compl … more →
wrote 3 years ago: WEDNESDAY, April 8 (HealthDay News) — An experimental tuberculosis vaccine called MVA85A proved safe … more →
wrote 3 years ago: There’s an interesting report in “Infection and Immunity” this week about the deve … more →
wrote 3 years ago: According to PETA: Medical historians have shown that improved nutrition and sanitation standards an … more →